DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis – A narrative review from the ECNP bipolar disorders network

Lars Vedel Kessing, Ana González-Pinto, Andrea Fagiolini, Andreas Bechdolf, Andreas Reif, Ayşegül Yildiz, Bruno Etain, Chantal Henry, Emanuel Severus, Eva Z. Reininghaus, Gunnar Morken, Guy M. Goodwin, Jan Scott, John R. Geddes, Marcella Rietschel, Mikael Landén, Mirko Manchia, Michael Bauer, Monica Martinez-Cengotitabengoa, Ole A. AndreassenPhilipp Ritter, Ralph Kupka, Rasmus W. Licht, René Ernst Nielsen, Thomas G. Schulze, Tomas Hajek, Trine Vik Lagerberg, Veerle Bergink, Eduard Vieta

Research output: Contribution to journalReview articlepeer-review

26 Citations (Scopus)
Original languageEnglish
Pages (from-to)54-61
Number of pages8
JournalEuropean Neuropsychopharmacology
Volume47
DOIs
Publication statusPublished - Jun 2021
Externally publishedYes

ASJC Scopus Subject Areas

  • Clinical Neurology
  • Neurology
  • Psychiatry and Mental health
  • Pharmacology (medical)
  • Biological Psychiatry
  • Pharmacology

Keywords

  • Bipolar disorder;DSM-5;ICD-11;Validity of diagnosis;Diagnostic delay;Delayed early intervention

Fingerprint

Dive into the research topics of 'DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis – A narrative review from the ECNP bipolar disorders network'. Together they form a unique fingerprint.

Cite this